Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.

Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3 in the footer, reflecting a site/version change rather than an update to the clinical trial record content.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3, reflecting an internal version update that does not alter the study details presented on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.3 applied, replacing v3.4.2. No user-visible changes to the study details page.SummaryDifference0.1%

- Check91 days agoChange DetectedOnly minor UI/version changes are observed: a new 'Revision: v3.4.2' label and removal of the older funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange DetectedAdded a government funding lapse notice with status updates and links to cc.nih.gov and opm.gov; added release note Revision: v3.4.1; removed the prior release note Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.